Veraxa Biotech Holding AG

EDGAR

Market value is not computed: this company’s US price is per depositary share, not per ordinary share.

11 filing records in this dataset, filed from 2025-07-31 to 2026-09-04. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Window: transactions dated on or after 2025-11-18.

Open-market purchases (code P)
5 transactions, 95,000 shares
Sum of shares × price per share: 125,332.66
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

  • 2026-10-28 Gruninger Marc P 9,133 1.00
  • 2026-10-27 Gruninger Marc P 867 0.98
  • 2026-10-20 Ziegler Christoph Samuel P 30,000 1.09
  • 2026-08-27 Baumann Oliver Rolf P 50,000 1.50
  • 2026-08-27 Antz Christoph Rudiger P 5,000 1.53

5% holders (Schedule 13D and 13G)

  • AQR Capital Management, LLC 0.46% SCHEDULE 13G/A 06/30/2026
  • AQR Capital Management Holdings, LLC 0.46% SCHEDULE 13G/A 06/30/2026
  • AQR Arbitrage, LLC 0.46% SCHEDULE 13G/A 06/30/2026

See all insider transactions

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Statement history is unavailable.

You can still inspect the reported figures or try loading the history again.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

11 filings · 24 latest values · 24 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0002079109, 2079109, edgar:2079109

Also known as Veraxa Biotech AG - Post de-SPAC, Veraxa Biotech Holding AG